VRTX — VERTEX PHARMACEUTICALS INC / MA
Nasdaq ·
Materials ·
Chemicals ·
CIK 875320 ·
Last close
$429.82
52W High
$507.92
52W Low
$362.50
ADV30
1,175,980
Last filing
2026-05-05
SIC
2834
No quarterly fundamentals indexed for this ticker.
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,240,600,000
Investing CF
$-1,321,500,000
Financing CF
$-2,119,700,000
CapEx
$-530,300,000
Dividends Paid
—
Buybacks
$-2,256,100,000
EPS Diluted TTM
$16.86
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$14,591,400,000
Inventory
$1,766,700,000
Receivables
$1,996,100,000
ST Investments
$1,753,800,000
EBIT TTM
$5,061,900,000
Pretax Income TTM
$5,165,700,000
Interest Exp TTM
$10,300,000
Analysts
28
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,218,000,384
EBITDA
$4,981,199,872
Free Cash Flow
$2,783,225,088
Enterprise Value
$103,830,446,080
Total Cash
$7,246,700,032
Total Debt
$1,986,499,968
Shares Out
253,805,417
Trailing EPS
$16.85
Book Value
$76.18
ROE
24.2%
ROA
12.1%
Div Yield
—
Recent Insider Activity
No insider activity indexed for this ticker.